Loading…

Postbiotic gel relieves clinical symptoms of bacterial vaginitis by regulating the vaginal microbiota

Vaginitis is the most common disease in gynecology. Vaginal dysbiosis is a main reason of bacteria vaginitis (BV), as the disrupted microecological environment facilitates the growth of various vaginal pathogens. The most dominant bacteria in the vaginal microbiota are lactic acid bacteria, which ar...

Full description

Saved in:
Bibliographic Details
Published in:Frontiers in cellular and infection microbiology 2023-02, Vol.13, p.1114364-1114364
Main Authors: Shen, Xin, Xu, Lin, Zhang, Zhiquan, Yang, Yitong, Li, Pengxian, Ma, Teng, Guo, Shuai, Kwok, Lai-Yu, Sun, Zhihong
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c468t-21a8f1ff55d7d03f42f039ebc0a01d48cd8e90d3a658b671185382bf0eecbc33
cites cdi_FETCH-LOGICAL-c468t-21a8f1ff55d7d03f42f039ebc0a01d48cd8e90d3a658b671185382bf0eecbc33
container_end_page 1114364
container_issue
container_start_page 1114364
container_title Frontiers in cellular and infection microbiology
container_volume 13
creator Shen, Xin
Xu, Lin
Zhang, Zhiquan
Yang, Yitong
Li, Pengxian
Ma, Teng
Guo, Shuai
Kwok, Lai-Yu
Sun, Zhihong
description Vaginitis is the most common disease in gynecology. Vaginal dysbiosis is a main reason of bacteria vaginitis (BV), as the disrupted microecological environment facilitates the growth of various vaginal pathogens. The most dominant bacteria in the vaginal microbiota are lactic acid bacteria, which are important for maintaining vaginal health. At present, antibiotics and other drugs are often used in clinical treatment, but there are many adverse reactions and easy to relapse, and the intervention of probiotics can help restore vaginal microbiota and alleviate BV. This study is a human clinical trial of 50 patients with bacterial vaginitis (BV). The alleviation effect of applying a postbiotic gel for one week in BV was evaluated. Changes in patients' clinical indicators of BV (properties of vaginal secretion) and the vaginal microbiota after using the postbiotic gel were monitored. Our results showed that apply the postbiotic gel improved the symptoms of BV, indicated by improvement in the abnormalities of patients' vaginal secretions. After applying the gel, the relative abundance of vaginal lactobacilli increased compared to baseline. Significant negative correlations were found between lactobacilli and potential vaginal pathogens (including , , and ), as well as the abnormalities of the vaginal secretion. Overall, our results showed that applying the postbiotic gel ameliorated BV, and the symptom improvement was accompanied by significant changes in the bacterial vaginal microbiota. Our study provides valuable clinical data in managing BV.
doi_str_mv 10.3389/fcimb.2023.1114364
format article
fullrecord <record><control><sourceid>proquest_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_2034575c4aa54ab59de44abbb82b8ed9</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_2034575c4aa54ab59de44abbb82b8ed9</doaj_id><sourcerecordid>2779343460</sourcerecordid><originalsourceid>FETCH-LOGICAL-c468t-21a8f1ff55d7d03f42f039ebc0a01d48cd8e90d3a658b671185382bf0eecbc33</originalsourceid><addsrcrecordid>eNpVkU1v3CAQhq2qUROl-QM5RD72sltgsA2XSlXUj0iR2kPuCPDgEGGzAXal_fdls9so4TJo3plnBt6muaZkDSDkV2f9bNaMMFhTSjn0_ENzwRh0KyaF-Pjmft5c5fxE6hkIExI-NefQC9p3Qlw0-DfmYnws3rYThjZh8LjD3NrgF291aPN-3pQ45za61mhbMPma3emp6sXn1uxr07QNuvhlassjHrVaM3ub4oGtPzdnToeMV6d42Tz8_PFw-3t1_-fX3e33-5XlvSgrRrVw1LmuG4eRgOPMEZBoLNGEjlzYUaAkI-i6u-kHSkUHghlHEK2xAJfN3RE7Rv2kNsnPOu1V1F69JGKalE71pQEVI8C7obNc645r08kReY3GVJ7AUVbWtyNrszUzjhaXknR4B32vLP5RTXGnpIQeKK2ALydAis9bzEXNPlsMQS8Yt1mxYZDAgfeklrJjaf2vnBO61zGUqIPb6sVtdXBbndyuTTdvF3xt-e8t_AMizqoV</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2779343460</pqid></control><display><type>article</type><title>Postbiotic gel relieves clinical symptoms of bacterial vaginitis by regulating the vaginal microbiota</title><source>PubMed Central</source><creator>Shen, Xin ; Xu, Lin ; Zhang, Zhiquan ; Yang, Yitong ; Li, Pengxian ; Ma, Teng ; Guo, Shuai ; Kwok, Lai-Yu ; Sun, Zhihong</creator><creatorcontrib>Shen, Xin ; Xu, Lin ; Zhang, Zhiquan ; Yang, Yitong ; Li, Pengxian ; Ma, Teng ; Guo, Shuai ; Kwok, Lai-Yu ; Sun, Zhihong</creatorcontrib><description>Vaginitis is the most common disease in gynecology. Vaginal dysbiosis is a main reason of bacteria vaginitis (BV), as the disrupted microecological environment facilitates the growth of various vaginal pathogens. The most dominant bacteria in the vaginal microbiota are lactic acid bacteria, which are important for maintaining vaginal health. At present, antibiotics and other drugs are often used in clinical treatment, but there are many adverse reactions and easy to relapse, and the intervention of probiotics can help restore vaginal microbiota and alleviate BV. This study is a human clinical trial of 50 patients with bacterial vaginitis (BV). The alleviation effect of applying a postbiotic gel for one week in BV was evaluated. Changes in patients' clinical indicators of BV (properties of vaginal secretion) and the vaginal microbiota after using the postbiotic gel were monitored. Our results showed that apply the postbiotic gel improved the symptoms of BV, indicated by improvement in the abnormalities of patients' vaginal secretions. After applying the gel, the relative abundance of vaginal lactobacilli increased compared to baseline. Significant negative correlations were found between lactobacilli and potential vaginal pathogens (including , , and ), as well as the abnormalities of the vaginal secretion. Overall, our results showed that applying the postbiotic gel ameliorated BV, and the symptom improvement was accompanied by significant changes in the bacterial vaginal microbiota. Our study provides valuable clinical data in managing BV.</description><identifier>ISSN: 2235-2988</identifier><identifier>EISSN: 2235-2988</identifier><identifier>DOI: 10.3389/fcimb.2023.1114364</identifier><identifier>PMID: 36816588</identifier><language>eng</language><publisher>Switzerland: Frontiers Media S.A</publisher><subject>Bacteria ; bacterial vaginitis ; Cellular and Infection Microbiology ; Female ; Gardnerella ; Humans ; lactobacilli ; Lactobacillus - physiology ; Microbiota ; postbiotic ; Vagina - microbiology ; vaginal microbiota ; Vaginosis, Bacterial - microbiology</subject><ispartof>Frontiers in cellular and infection microbiology, 2023-02, Vol.13, p.1114364-1114364</ispartof><rights>Copyright © 2023 Shen, Xu, Zhang, Yang, Li, Ma, Guo, Kwok and Sun.</rights><rights>Copyright © 2023 Shen, Xu, Zhang, Yang, Li, Ma, Guo, Kwok and Sun 2023 Shen, Xu, Zhang, Yang, Li, Ma, Guo, Kwok and Sun</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c468t-21a8f1ff55d7d03f42f039ebc0a01d48cd8e90d3a658b671185382bf0eecbc33</citedby><cites>FETCH-LOGICAL-c468t-21a8f1ff55d7d03f42f039ebc0a01d48cd8e90d3a658b671185382bf0eecbc33</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC9936311/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC9936311/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,881,27901,27902,53766,53768</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/36816588$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Shen, Xin</creatorcontrib><creatorcontrib>Xu, Lin</creatorcontrib><creatorcontrib>Zhang, Zhiquan</creatorcontrib><creatorcontrib>Yang, Yitong</creatorcontrib><creatorcontrib>Li, Pengxian</creatorcontrib><creatorcontrib>Ma, Teng</creatorcontrib><creatorcontrib>Guo, Shuai</creatorcontrib><creatorcontrib>Kwok, Lai-Yu</creatorcontrib><creatorcontrib>Sun, Zhihong</creatorcontrib><title>Postbiotic gel relieves clinical symptoms of bacterial vaginitis by regulating the vaginal microbiota</title><title>Frontiers in cellular and infection microbiology</title><addtitle>Front Cell Infect Microbiol</addtitle><description>Vaginitis is the most common disease in gynecology. Vaginal dysbiosis is a main reason of bacteria vaginitis (BV), as the disrupted microecological environment facilitates the growth of various vaginal pathogens. The most dominant bacteria in the vaginal microbiota are lactic acid bacteria, which are important for maintaining vaginal health. At present, antibiotics and other drugs are often used in clinical treatment, but there are many adverse reactions and easy to relapse, and the intervention of probiotics can help restore vaginal microbiota and alleviate BV. This study is a human clinical trial of 50 patients with bacterial vaginitis (BV). The alleviation effect of applying a postbiotic gel for one week in BV was evaluated. Changes in patients' clinical indicators of BV (properties of vaginal secretion) and the vaginal microbiota after using the postbiotic gel were monitored. Our results showed that apply the postbiotic gel improved the symptoms of BV, indicated by improvement in the abnormalities of patients' vaginal secretions. After applying the gel, the relative abundance of vaginal lactobacilli increased compared to baseline. Significant negative correlations were found between lactobacilli and potential vaginal pathogens (including , , and ), as well as the abnormalities of the vaginal secretion. Overall, our results showed that applying the postbiotic gel ameliorated BV, and the symptom improvement was accompanied by significant changes in the bacterial vaginal microbiota. Our study provides valuable clinical data in managing BV.</description><subject>Bacteria</subject><subject>bacterial vaginitis</subject><subject>Cellular and Infection Microbiology</subject><subject>Female</subject><subject>Gardnerella</subject><subject>Humans</subject><subject>lactobacilli</subject><subject>Lactobacillus - physiology</subject><subject>Microbiota</subject><subject>postbiotic</subject><subject>Vagina - microbiology</subject><subject>vaginal microbiota</subject><subject>Vaginosis, Bacterial - microbiology</subject><issn>2235-2988</issn><issn>2235-2988</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><sourceid>DOA</sourceid><recordid>eNpVkU1v3CAQhq2qUROl-QM5RD72sltgsA2XSlXUj0iR2kPuCPDgEGGzAXal_fdls9so4TJo3plnBt6muaZkDSDkV2f9bNaMMFhTSjn0_ENzwRh0KyaF-Pjmft5c5fxE6hkIExI-NefQC9p3Qlw0-DfmYnws3rYThjZh8LjD3NrgF291aPN-3pQ45za61mhbMPma3emp6sXn1uxr07QNuvhlassjHrVaM3ub4oGtPzdnToeMV6d42Tz8_PFw-3t1_-fX3e33-5XlvSgrRrVw1LmuG4eRgOPMEZBoLNGEjlzYUaAkI-i6u-kHSkUHghlHEK2xAJfN3RE7Rv2kNsnPOu1V1F69JGKalE71pQEVI8C7obNc645r08kReY3GVJ7AUVbWtyNrszUzjhaXknR4B32vLP5RTXGnpIQeKK2ALydAis9bzEXNPlsMQS8Yt1mxYZDAgfeklrJjaf2vnBO61zGUqIPb6sVtdXBbndyuTTdvF3xt-e8t_AMizqoV</recordid><startdate>20230202</startdate><enddate>20230202</enddate><creator>Shen, Xin</creator><creator>Xu, Lin</creator><creator>Zhang, Zhiquan</creator><creator>Yang, Yitong</creator><creator>Li, Pengxian</creator><creator>Ma, Teng</creator><creator>Guo, Shuai</creator><creator>Kwok, Lai-Yu</creator><creator>Sun, Zhihong</creator><general>Frontiers Media S.A</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope></search><sort><creationdate>20230202</creationdate><title>Postbiotic gel relieves clinical symptoms of bacterial vaginitis by regulating the vaginal microbiota</title><author>Shen, Xin ; Xu, Lin ; Zhang, Zhiquan ; Yang, Yitong ; Li, Pengxian ; Ma, Teng ; Guo, Shuai ; Kwok, Lai-Yu ; Sun, Zhihong</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c468t-21a8f1ff55d7d03f42f039ebc0a01d48cd8e90d3a658b671185382bf0eecbc33</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Bacteria</topic><topic>bacterial vaginitis</topic><topic>Cellular and Infection Microbiology</topic><topic>Female</topic><topic>Gardnerella</topic><topic>Humans</topic><topic>lactobacilli</topic><topic>Lactobacillus - physiology</topic><topic>Microbiota</topic><topic>postbiotic</topic><topic>Vagina - microbiology</topic><topic>vaginal microbiota</topic><topic>Vaginosis, Bacterial - microbiology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Shen, Xin</creatorcontrib><creatorcontrib>Xu, Lin</creatorcontrib><creatorcontrib>Zhang, Zhiquan</creatorcontrib><creatorcontrib>Yang, Yitong</creatorcontrib><creatorcontrib>Li, Pengxian</creatorcontrib><creatorcontrib>Ma, Teng</creatorcontrib><creatorcontrib>Guo, Shuai</creatorcontrib><creatorcontrib>Kwok, Lai-Yu</creatorcontrib><creatorcontrib>Sun, Zhihong</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Frontiers in cellular and infection microbiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Shen, Xin</au><au>Xu, Lin</au><au>Zhang, Zhiquan</au><au>Yang, Yitong</au><au>Li, Pengxian</au><au>Ma, Teng</au><au>Guo, Shuai</au><au>Kwok, Lai-Yu</au><au>Sun, Zhihong</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Postbiotic gel relieves clinical symptoms of bacterial vaginitis by regulating the vaginal microbiota</atitle><jtitle>Frontiers in cellular and infection microbiology</jtitle><addtitle>Front Cell Infect Microbiol</addtitle><date>2023-02-02</date><risdate>2023</risdate><volume>13</volume><spage>1114364</spage><epage>1114364</epage><pages>1114364-1114364</pages><issn>2235-2988</issn><eissn>2235-2988</eissn><abstract>Vaginitis is the most common disease in gynecology. Vaginal dysbiosis is a main reason of bacteria vaginitis (BV), as the disrupted microecological environment facilitates the growth of various vaginal pathogens. The most dominant bacteria in the vaginal microbiota are lactic acid bacteria, which are important for maintaining vaginal health. At present, antibiotics and other drugs are often used in clinical treatment, but there are many adverse reactions and easy to relapse, and the intervention of probiotics can help restore vaginal microbiota and alleviate BV. This study is a human clinical trial of 50 patients with bacterial vaginitis (BV). The alleviation effect of applying a postbiotic gel for one week in BV was evaluated. Changes in patients' clinical indicators of BV (properties of vaginal secretion) and the vaginal microbiota after using the postbiotic gel were monitored. Our results showed that apply the postbiotic gel improved the symptoms of BV, indicated by improvement in the abnormalities of patients' vaginal secretions. After applying the gel, the relative abundance of vaginal lactobacilli increased compared to baseline. Significant negative correlations were found between lactobacilli and potential vaginal pathogens (including , , and ), as well as the abnormalities of the vaginal secretion. Overall, our results showed that applying the postbiotic gel ameliorated BV, and the symptom improvement was accompanied by significant changes in the bacterial vaginal microbiota. Our study provides valuable clinical data in managing BV.</abstract><cop>Switzerland</cop><pub>Frontiers Media S.A</pub><pmid>36816588</pmid><doi>10.3389/fcimb.2023.1114364</doi><tpages>1</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2235-2988
ispartof Frontiers in cellular and infection microbiology, 2023-02, Vol.13, p.1114364-1114364
issn 2235-2988
2235-2988
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_2034575c4aa54ab59de44abbb82b8ed9
source PubMed Central
subjects Bacteria
bacterial vaginitis
Cellular and Infection Microbiology
Female
Gardnerella
Humans
lactobacilli
Lactobacillus - physiology
Microbiota
postbiotic
Vagina - microbiology
vaginal microbiota
Vaginosis, Bacterial - microbiology
title Postbiotic gel relieves clinical symptoms of bacterial vaginitis by regulating the vaginal microbiota
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-02T21%3A13%3A38IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Postbiotic%20gel%20relieves%20clinical%20symptoms%20of%20bacterial%20vaginitis%20by%20regulating%20the%20vaginal%20microbiota&rft.jtitle=Frontiers%20in%20cellular%20and%20infection%20microbiology&rft.au=Shen,%20Xin&rft.date=2023-02-02&rft.volume=13&rft.spage=1114364&rft.epage=1114364&rft.pages=1114364-1114364&rft.issn=2235-2988&rft.eissn=2235-2988&rft_id=info:doi/10.3389/fcimb.2023.1114364&rft_dat=%3Cproquest_doaj_%3E2779343460%3C/proquest_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c468t-21a8f1ff55d7d03f42f039ebc0a01d48cd8e90d3a658b671185382bf0eecbc33%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2779343460&rft_id=info:pmid/36816588&rfr_iscdi=true